Abstracts

EARLY bNAb THERAPY IN SHIVAD8-EO–INFECTED RHESUS MACAQUES

Co-administration of the anti-HIV-1 bNAbs 10-1074 and 3BNC117 to SHIV-infected monkeys at days 3, 10, and 17 post-challenge led to long-term CD8+ T cell-mediated control of infection in half of the monkeys (Nishimura et al., Nature, 2017). A possible mechanism behind virus control is that bNAbs form immune complexes with SHIV, leading to its cross-presentation…

IMMUNE CORRELATES OF POSTTREATMENT CONTROL IN SHIV-INFECTED INFANT MACAQUES

Breastfeeding transmission accounts for the majority of new pediatric HIV infections and commits infants to lifelong ART, as interruption is typically followed by return of replication and repopulation of reservoirs. Previous studies in adult humans and animal models have identified correlates of viral control following analytical treatment interruption (ATI). However, it is critical to understand…

POSTDISCHARGE OUTCOMES FOLLOWING ACUTE CORONARY SYNDROME IN HIV

HIV-infected individuals are at increased risk of cardiovascular death. Most of this risk can be attributed to ischemic heart disease. Differences in the management of HIV-infected patients following hospitalization for acute coronary syndromes (ACS) may contribute to worsened outcomes in this population. We hypothesized that HIV-infected individuals have higher rates of mortality following discharge, and receive…